# HMPL-523 Food Effect and Proton Pump Inhibitor Study

> **NCT05571787** · PHASE1 · COMPLETED · sponsor: **Hutchmed** · enrollment: 26 (actual)

## Conditions studied

- Relapsed or Refractory Lymphoma

## Interventions

- **DRUG:** HMPL-523
- **DRUG:** Rabeprazole

## Key facts

- **NCT ID:** NCT05571787
- **Lead sponsor:** Hutchmed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-13
- **Primary completion:** 2022-09-22
- **Final completion:** 2022-09-22
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05571787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05571787, "HMPL-523 Food Effect and Proton Pump Inhibitor Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05571787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*